As noted above, in our analysis comparing THCs with NHCs in the colon cancer dataset, we found increased KRAS and TP53 signaling in THCs, which, as we previously noted, are frequently deregulated in colon cancers. The gene discussed is KRAS; the disease is malignant colon neoplasm.